FSD Pharma Inc - Class B - Class B (Sub Voting)
Research FSD Pharma Inc - Class B - Class B (Sub Voting) (QNTM) on Bullrun: market cap USD 21.37M. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerQNTM
- ExchangeNASDAQ
- CountryCanada
- SectorHealthcare
- IndustryBiotechnology
- CurrencyUSD
- Market capUSD 21.37M
- Financial periodQ2 2026
- RevenueUSD 0
- Net income-USD 3.25M
- Free cash flow-USD 1.79M
Valuation Snapshot
latest market cap is USD 21.37M.
Five-year financial history
| Year | Revenue | Net income | Free cash flow | Gross margin | Diluted EPS | Cash | Total debt | Equity |
|---|---|---|---|---|---|---|---|---|
| FY2025 | USD 0 | -USD 26.18M | -USD 8.24M | n/a | -8.2 | USD 1.91M | USD 1.88M | USD 6.92M |
| FY2024 | USD 0 | -USD 14.20M | -USD 6.88M | n/a | -13.12 | USD 6.00M | USD 824.92K | USD 11.48M |
| FY2023 | USD 0 | -USD 17.90M | -USD 10.83M | n/a | -29.93 | USD 2.76M | USD 339.20K | USD 13.24M |
| FY2022 | USD 0 | -USD 23.61M | -USD 28.70M | n/a | -39.61 | USD 16.98M | USD 516.42K | USD 30.54M |
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-10-12 | USD 21.37M | n/a | n/a | n/a |
| 2025 | 2025-12-31 | USD 28.38M | n/a | n/a | n/a |
| 2024 | 2024-12-31 | USD 8.46M | n/a | n/a | n/a |
| 2023 | 2023-12-29 | USD 36.23M | n/a | n/a | n/a |
| 2022 | 2022-12-30 | USD 30.03M | n/a | n/a | n/a |
| 2021 | 2021-12-31 | USD 41.26M | n/a | n/a | n/a |
About FSD Pharma Inc - Class B - Class B (Sub Voting)
Quantum BioPharma Ltd., together with its subsidiaries, operates as a biopharmaceutical company. The company operates through two segments, Biopharmaceutical Innovation and Strategic Investments. It researches and develops a portfolio of assets and biotech solutions for the treatment of neurodegenerative, inflammatory and metabolic disorders, and alcohol misuse disorders with drug candidates in different stages of development.
Related stock research
Other Healthcare stocks
Frequently asked questions
What is FSD Pharma Inc - Class B - Class B (Sub Voting)'s market cap?
FSD Pharma Inc - Class B - Class B (Sub Voting)'s market capitalization is USD 21.37M.
What does FSD Pharma Inc - Class B - Class B (Sub Voting) do?
Quantum BioPharma Ltd., together with its subsidiaries, operates as a biopharmaceutical company. The company operates through two segments, Biopharmaceutical Innovation and Strategic Investments. It researches and develops a portfolio of assets and biotech solutions for the treatment of neurodegenerative, inflammatory and metabolic disorders, and alcohol misuse disorders with drug candidates in different stages of development.